GSK - Analyst consensus points to cautious Hold stance
Published on 06/17/2026 at 17:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 17:38 CET. Details in the imprint.
GSK (GB0009252882) sits in the middle of the pack on the London market with a broadly neutral analyst view. The latest consensus data from MarketBeat show a Hold rating and only limited expected upside over the next twelve months.
All news and analysis on GSK stock
Key figures, background and further news on GSK stock can be found in the dedicated topic section and on the company’s Investor Relations pages.
What the analysts say
According to MarketBeat, seven analysts currently cover GSK, with one Sell, four Hold and two Buy recommendations, resulting in an overall Hold consensus. The average 12-month price target stands at GBX 2,034.29, only modestly above the present share price.
The price target range is wide: the highest target is GBX 2,500, while the lowest is GBX 1,500. This spread underlines how divided the analyst community is on GSK’s medium-term earnings and pipeline prospects.
Consensus in a sector context
At around GBX 1,950 in London trading, GSK shares change hands slightly below the average analyst target, implying an upside of just over 4% on consensus numbers. Other big pharma names often trade with higher implied upside when sentiment is more constructive.
Sector peers such as Eli Lilly and Johnson & Johnson are frequently referenced alongside GSK on market data platforms, highlighting the competitive backdrop in pharmaceuticals and vaccines. Against this peer group, GSK’s Hold consensus reflects a cautious but not negative stance.
How the company makes money
GSK focuses on vaccines and specialty medicines, including respiratory, HIV, oncology and immunology treatments. The group also generates revenue from general medicines across a broad portfolio, from inhaled therapies to antibiotics and other primary-care drugs.
Where the stock trades today
The shares of GSK (GB0009252882) trade on the London Stock Exchange at about GBX 1,950 as of 06/17/2026, 17:30 CET.
Key facts on GSK stock
- Company: GSK plc
- ISIN: GB0009252882
- WKN: 940561
- Ticker: GSK
- Venue: London Stock Exchange
- Price (as of 06/17/2026, 17:30 CET): 1,950.00 GBX
- Market cap: around GBP 80 billion (as of 06/17/2026)
- Sector / Industry: Health Care / Pharmaceuticals & Biotechnology
- Index membership: FTSE 100
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
